Featured Research

from universities, journals, and other organizations

Punching Holes Into Herpes Viruses

Date:
June 20, 2009
Source:
VU University Amsterdam
Summary:
Scientists have completed the first description of the mechanics of so-called nuclear herpes virus capsids.

A joint international research effort by Dr. Wouter Roos and Dr. Gijs Wuite from the VU University Amsterdam and Dr. Kerstin Radtke and Dr. Beate Sodeik from the Medizinische Hochschule Hannover has led to the first description of the mechanics of so-called nuclear herpes virus capsids.

These viral particles are complex icosahedral protein shells covering and shielding the genetic material of herpes viruses, and are purified from the nuclei of infected cells. The results of this research were published online on June 1st, 2009 in the journal Proceedings of the National Academy of Sciences USA.

Nuclear Herpes Simplex Virus particles measure only 125 nanometers (approximately one ten-thousandth of a millimeter), therefore, the structure and surface of individual particles can only be studied with methods that have a resolution that is higher than that of a light microscope. With the help of an Atomic Force Microscope, one can now "feel" the particles and image them by scanning systematically over the surface, like the needle on a record player. From these measurements, researchers can assemble a detailed topographic relief of individual viral structures. This can be done in liquid under conditions mimicking living cells. Most importantly, this system allows the mechanical manipulation of particles, as one really touches them.

The researchers used this approach to gain new insights into the mechanics of these viral particles: they punched holes into them, one by one. The force needed to do this gave information about the elastic and mechanical properties of the herpes virus particles. They showed that they are strengthened during the assembly by packaging of the viral DNA into the shell. This reinforcement of the virus probably occurs at the twelve corner points of its icosahedral shell. The unravelling of this viral stabilisation mechanism could open new possibilities to fight herpes infections but could also provide new ways to employ viral particles as nano-containers for delivering drugs or genetic material.


Story Source:

The above story is based on materials provided by VU University Amsterdam. Note: Materials may be edited for content and length.


Cite This Page:

VU University Amsterdam. "Punching Holes Into Herpes Viruses." ScienceDaily. ScienceDaily, 20 June 2009. <www.sciencedaily.com/releases/2009/06/090611194127.htm>.
VU University Amsterdam. (2009, June 20). Punching Holes Into Herpes Viruses. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2009/06/090611194127.htm
VU University Amsterdam. "Punching Holes Into Herpes Viruses." ScienceDaily. www.sciencedaily.com/releases/2009/06/090611194127.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins